160 related articles for article (PubMed ID: 26434836)
1. Inhibitory Aromatase Effects of Flavonoids from Ginkgo Biloba Extracts on Estrogen Biosynthesis.
Park YJ; Choo WH; Kim HR; Chung KH; Oh SM
Asian Pac J Cancer Prev; 2015; 16(15):6317-25. PubMed ID: 26434836
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of aromatase (CYP19).
Lu DF; Yang LJ; Wang F; Zhang GL
J Agric Food Chem; 2012 Aug; 60(34):8411-8. PubMed ID: 22838964
[TBL] [Abstract][Full Text] [Related]
3. VERIFICATION OF AUTHENTICITY OF
Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
[No Abstract] [Full Text] [Related]
4. The inhibitory effects of the standardized extracts of Ginkgo biloba on Aromatase activity in JEG-3 human choriocarcinoma cells.
Kim MJ; Park YJ; Chung KH; Oh SM
Phytother Res; 2013 Dec; 27(12):1756-62. PubMed ID: 23339036
[TBL] [Abstract][Full Text] [Related]
5. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic activities of Ginkgo biloba extracts.
Oh SM; Chung KH
Life Sci; 2004 Jan; 74(11):1325-35. PubMed ID: 14706564
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol and quercetin, essential ingredients in Ginkgo biloba extract, inhibit interleukin-1beta-induced MUC5AC gene expression in human airway epithelial cells.
Kwon SH; Nam JI; Kim SH; Kim JH; Yoon JH; Kim KS
Phytother Res; 2009 Dec; 23(12):1708-12. PubMed ID: 19367675
[TBL] [Abstract][Full Text] [Related]
9. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
Lee HS; Kim MJ
J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
11. Phytochemicals for breast cancer prevention by targeting aromatase.
Adams LS; Chen S
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3846-63. PubMed ID: 19273315
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells.
Wang Y; Leung LK
Toxicol Lett; 2007 Sep; 173(3):175-80. PubMed ID: 17766065
[TBL] [Abstract][Full Text] [Related]
13. Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer.
Park YJ; Ahn HY; Kim HR; Chung KH; Oh SM
Food Chem Toxicol; 2016 Jan; 87():157-65. PubMed ID: 26706698
[TBL] [Abstract][Full Text] [Related]
14. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
[TBL] [Abstract][Full Text] [Related]
16. Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19).
Yang L; Lu D; Guo J; Meng X; Zhang G; Wang F
J Ethnopharmacol; 2013 Feb; 145(3):715-21. PubMed ID: 23261485
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Ginkgo biloba extract on fatty liver: regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism.
Wang SD; Xie ZQ; Chen J; Wang K; Wei T; Zhao AH; Zhang QH
J Dig Dis; 2012 Oct; 13(10):525-35. PubMed ID: 22988926
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CYP1A1 activity by a Ginkgo biloba extract in the human intestinal Caco-2 cells.
Ribonnet L; Callebaut A; Nobels I; Scippo ML; Schneider YJ; De Saeger S; Pussemier L; Larondelle Y
Toxicol Lett; 2011 May; 202(3):193-202. PubMed ID: 21329749
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.
Ude C; Schubert-Zsilavecz M; Wurglics M
Clin Pharmacokinet; 2013 Sep; 52(9):727-49. PubMed ID: 23703577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
